Carrera Capital Advisors Reduces Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Carrera Capital Advisors lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 4.9% during the third quarter, HoldingsChannel reports. The firm owned 506 shares of the healthcare conglomerate’s stock after selling 26 shares during the period. Carrera Capital Advisors’ holdings in UnitedHealth Group were worth $296,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in UNH. Kathleen S. Wright Associates Inc. acquired a new stake in shares of UnitedHealth Group during the third quarter valued at about $27,000. Global Wealth Strategies & Associates increased its holdings in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the last quarter. Macroview Investment Management LLC grew its position in shares of UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after buying an additional 47 shares in the last quarter. West Financial Advisors LLC acquired a new stake in UnitedHealth Group in the third quarter valued at $32,000. Finally, Delos Wealth Advisors LLC grew its holdings in UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 53 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms recently commented on UNH. Argus lifted their price target on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Morgan Stanley dropped their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. Truist Financial reiterated a “buy” rating and set a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 24th. Finally, Stephens cut their target price on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $615.53.

View Our Latest Report on UNH

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded down $9.46 on Tuesday, reaching $615.79. 957,172 shares of the company traded hands, compared to its average volume of 3,888,556. The company’s 50 day moving average is $582.63 and its 200-day moving average is $546.78. The stock has a market capitalization of $566.70 billion, a PE ratio of 40.73, a P/E/G ratio of 1.81 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same period last year, the company posted $6.56 earnings per share. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.36%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.